| ABC transporters in cancer: more than just drug efflux pumps JI Fletcher, M Haber, MJ Henderson, MD Norris Nature Reviews Cancer 10 (2), 147-156, 2010 | 1228 | 2010 |
| Taxol-resistant epithelial ovarian tumors are associated with altered expression of specific beta-tubulin isotypes. M Kavallaris, DY Kuo, CA Burkhart, DL Regl, MD Norris, M Haber, ... The Journal of clinical investigation 100 (5), 1282-1293, 1997 | 769 | 1997 |
| International consensus for neuroblastoma molecular diagnostics: report from the International Neuroblastoma Risk Group (INRG) Biology Committee PF Ambros, IM Ambros, GM Brodeur, M Haber, J Khan, A Nakagawara, ... British journal of cancer 100 (9), 1471-1482, 2009 | 449 | 2009 |
| ABC transporters as mediators of drug resistance and contributors to cancer cell biology JI Fletcher, RT Williams, MJ Henderson, MD Norris, M Haber Drug Resistance Updates 26, 1-9, 2016 | 425 | 2016 |
| Expression of the gene for multidrug-resistance–associated protein and outcome in patients with neuroblastoma MD Norris, SB Bordow, GM Marshall, PS Haber, SL Cohn, M Haber New England Journal of Medicine 334 (4), 231-238, 1996 | 416 | 1996 |
| Role of the MRP1/ABCC1 multidrug transporter protein in cancer M Munoz, M Henderson, M Haber, M Norris IUBMB life 59 (12), 752-757, 2007 | 296 | 2007 |
| Multiple microtubule alterations are associated with Vinca alkaloid resistance in human leukemia cells M Kavallaris, AS Tait, BJ Walsh, L He, SB Horwitz, MD Norris, M Haber Cancer research 61 (15), 5803-5809, 2001 | 285 | 2001 |
| Characterization of childhood acute lymphoblastic leukemia xenograft models for the preclinical evaluation of new therapies NLM Liem, RA Papa, CG Milross, MA Schmid, M Tajbakhsh, S Choi, ... Blood 103 (10), 3905-3914, 2004 | 257 | 2004 |
| ODC1 is a critical determinant of MYCN oncogenesis and a therapeutic target in neuroblastoma MD Hogarty, MD Norris, K Davis, X Liu, NF Evageliou, CS Hayes, B Pawel, ... Cancer research 68 (23), 9735-9745, 2008 | 245 | 2008 |
| miR-380-5p represses p53 to control cellular survival and is associated with poor outcome in MYCN-amplified neuroblastoma A Swarbrick, SL Woods, A Shaw, A Balakrishnan, Y Phua, A Nguyen, ... Nature medicine 16 (10), 1134-1140, 2010 | 237 | 2010 |
| Expression of the Multidrug Resistance-associated Protein (MRP) Gene Correlates with Amplification and Overexpression of the N-myc Oncogene in Childhood … SB Bordow, M Haber, J Madafiglio, B Cheung, GM Marshall, MD Norris Cancer research 54 (19), 5036-5040, 1994 | 234 | 1994 |
| The nonobese diabetic/severe combined immunodeficient (NOD/SCID) mouse model of childhood acute lymphoblastic leukemia reveals intrinsic differences in biologic characteristics … RB Lock, N Liem, ML Farnsworth, CG Milross, C Xue, M Tajbakhsh, ... Blood, The Journal of the American Society of Hematology 99 (11), 4100-4108, 2002 | 231 | 2002 |
| The histone deacetylase SIRT2 stabilizes Myc oncoproteins PY Liu, N Xu, A Malyukova, CJ Scarlett, YT Sun, XD Zhang, D Ling, SP Su, ... Cell Death & Differentiation 20 (3), 503-514, 2013 | 226 | 2013 |
| Association of High-Level MRP1 Expression With Poor Clinical Outcome in a Large Prospective Study of Primary Neuroblastoma M Haber, J Smith, SB Bordow, C Flemming, SL Cohn, WB London, ... Journal of clinical oncology 24 (10), 1546-1553, 2006 | 225 | 2006 |
| Whole genome, transcriptome and methylome profiling enhances actionable target discovery in high-risk pediatric cancer M Wong, C Mayoh, LMS Lau, DA Khuong-Quang, M Pinese, A Kumar, ... Nature medicine 26 (11), 1742-1753, 2020 | 214 | 2020 |
| Intratumoral copper modulates PD-L1 expression and influences tumor immune evasion F Voli, E Valli, L Lerra, K Kimpton, F Saletta, FM Giorgi, D Mercatelli, ... Cancer research 80 (19), 4129-4144, 2020 | 199 | 2020 |
| The p53 pathway and its inactivation in neuroblastoma DA Tweddle, ADJ Pearson, M Haber, MD Norris, C Xue, C Flemming, ... Cancer letters 197 (1-2), 93-98, 2003 | 196 | 2003 |
| Altered Expression of Mβ2, the Class II β-Tubulin Isotype, in a Murine J774. 2 Cell Line with a High Level of Taxol Resistance (∗) M Haber, CA Burkhart, DL Regl, J Madafiglio, MD Norris, SB Horwitz Journal of Biological Chemistry 270 (52), 31269-31275, 1995 | 193 | 1995 |
| Mechanisms of embryonal tumor initiation: distinct roles for MycN expression and MYCN amplification LM Hansford, WD Thomas, JM Keating, CA Burkhart, AE Peaston, ... Proceedings of the National Academy of Sciences 101 (34), 12664-12669, 2004 | 192 | 2004 |
| Segmental chromosomal alterations have prognostic impact in neuroblastoma: a report from the INRG project G Schleiermacher, V Mosseri, WB London, JM Maris, GM Brodeur, ... British journal of cancer 107 (8), 1418-1422, 2012 | 189 | 2012 |
